The analysis of the mRNA level of the ATM gene did not show a significant change in its expression in patients with ovarian cancer compared with the control group (75.45% ± 5.56 vs. 100% ± 4.26; p > 0.05) (Table 3). This evidence concerns the gene ATM and ovarian carcinoma.